Metabolomics is an emerging science which is used in measurement and analysis of metabolite such as fats and sugar in the cell of organisms under a specific conditions and at specific times. Advance analytical technologies are used in metabolomics to obtain or identify the characteristics of metabolites which are present in various tissues, fluids, and organisms.
The global metabolomics market report has been segmented on the basis of product and service, application, indication, and region. Manufacturing companies are focusing on development of advance technique which enables to improve the diagnosis of a disease. This in turn is expected to boost the market growth over the forecast period. Increasing awareness regarding metabolomics owing to the numerous benefits in various therapeutic areas is another factor expected to drive the growth of global metabolomics market over the forecast period.
Application segment includes drug discovery, biomarker discovery, nutrigenomics, clinical toxicology, and others (functional genomics and personalized medicine). The biomarker discovery segment accounts largest share of the global metabolomics market. This is attributed to the increasing prevalence of diseases such as cancer, cardiovascular disorders and neurological disorders across the globe.
Do Inquiry of the Report Here: https://marketresearch.biz/report/metabolomics-market/#inquiry
Regional segmentation includes North America, Europe, Latin America, Asia Pacific and Middle East and Africa. North America contributes major market share and expected to maintain its dominance over the forecast period owing to the high adoption of advance techniques and presence of large number of players in the region. Asia Pacific region is expected to witness rapid growth rate over the forecast period. Countries like India, China, Japan is expected to support the growth of Asia Pacific, owing to the increasing demand for advanced technologies for accurate diagnosis of diseases.
Some prominent players in the global metabolomics market are Thermo Fisher Scientific, Agilent Technologies, Inc., Waters Corporation, Danaher Corporation, Shimadzu Corporation, Biocrates Life Sciences AG, Bio-Rad Laboratories, Inc., Bruker Corporation, Human Metabolome Technologies, Inc., and Leco Corporation.